期刊文献+

区域性化疗在胰腺癌中的应用 被引量:1

Reginal chemotherapy for pancreas carcinoma
下载PDF
导出
摘要 由于胰腺癌自身的生物学特征 ,手术效果不佳 ,对放疗、化疗不敏感 ,耐药性强 ,目前尚缺乏明显有效的治疗手段。系统性化疗对胰腺癌的效果有限 ,以 5 FU为主多种方案的反应率均不超过 2 0 % ,中位生存期仅为 6个月 ,除吉西他滨以外其他药物并不证明更有效。而区域性化疗目前显示出其在反应率、生存期。
出处 《中国普通外科杂志》 CAS CSCD 2004年第10期777-779,共3页 China Journal of General Surgery
  • 相关文献

参考文献20

  • 1Lorenz M,Heinrich S.Rejional chemotherapy[J].Hematol Oncol Clin N Am,2002,16(1):199-215.
  • 2Hakansson L,Hakansson A,Morales O,et al.Spherex(Degradable Starch Microspheres)chemo-occlusion-enhancement of tumor drug concentration and therapeutic efficacy:an overview[J].Semi Oncol,1997,24(2 supple 6):100-109.
  • 3NCI.Common toxicity criteria[EB/OL].http//www.fda.gov/cder/cancer/toxicity frame.htm.
  • 4ünal AE,Bayar S.Reginal chemotherapy-induced cure for pancreatic headcancer[J].Hepatogastroenterology,2002,49(44):556-557.
  • 5Muchmore JH,Carter RD,Preslan JE,et al.Regional chemotherapy with hemofiltration:A rationale for a different treatment approach to advanced pancreatic cancer[J].Hepatogastroenterology,1996,43(8):346-355.
  • 6Ohigashi H,Ishikawa O,Yokayama S,et al.Intra-arterial infusion chemotherapy with angiotensin-II for locally advanced and nonresectable pancreatic advnocarcinoma:further evaluation and prognostic implications[J].Ann Surg Oncol,2003,10(8):927-934.
  • 7Barletta E,Fiore F,Daniele B,et al.Intra-arterial second-line chemotherapy with 5-fluorouracil,leucovorin,epidoxorubicin and carboplatin(flec) for advanced adenocarcinoma of the pancreas[J].Ann Oncol,2003,14(Supplement 4):40-41.
  • 8王为民,许海明,等.区域动脉灌注化疗治疗不可切除胰腺癌[J].中华国际医学杂志,2002,2(4):367-368. 被引量:1
  • 9鲍洛文,倪耀忠.胰腺癌的区域性动脉灌注化疗[J].肝胆胰外科杂志,2002,14(2):92-93. 被引量:4
  • 10李占元,田川,吴清.晚期胰腺癌行区域化疗的疗效分析[J].山东大学学报(医学版),2002,40(6):550-551. 被引量:4

二级参考文献11

共引文献8

同被引文献12

  • 1孙家邦.胰腺癌外科治疗的术式选择[J].临床外科杂志,2005,13(4):201-202. 被引量:1
  • 2高云朝,陆云,程伟,邓守真,高泉,张学平,吴文清,倪泉兴,刘兴党,林祥通.血清肿瘤标志物在胰腺癌诊断中的选择[J].上海医学,2005,28(4):330-331. 被引量:6
  • 3SENER S F, FREMGEN A, MENCK H R, et al. Pancreatic cancer: a report of treatment and surgical trends for 100313 patients diprosed from 1985 to 1995, using the National Cancer Datebase [J]. J Am Coll Surg, 1999, 189 (1) : 1 -7.
  • 4ARIYAMAJ, SUYAMA M, SATOH K, et al. Imaging of small pancreatic ductal adenocarcinoma [J]. Pancreas, 1998, 16: 396.
  • 5APPLE S K, HECHT M, LEWIN D N, et al. Immunohist oche mica levaluation of K - ras, p53 and HER - 2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for muhistep carcinogenesis [ J]. Hum Pathol, 1999, 30 (2) : 23.
  • 6ROSTY C, GOGGINS M. Early detection of pancreatic carcinoma [J]. Hematol Oncol Clin North Am, 2002, 16:37 -52.
  • 7TATEISHI K, TADA M, YAMAGATA M, et al. Highproportion of mutant K - ras gene in pancreatic juice of patients with pancreatic cystic lesion [J]. Gut, 1999, 45 (5): 737.
  • 8FREENY P C. Pancreatic carcinoma: what is the best imaging test [J]. Pancreatology, 2001, 1(6) : 604 -609.
  • 9YEO C J, CAMERON J L, LILLEMOE K D, et al. Pancreaticoduodeneclomy with or without distal gastrectomy and exiended retroperitoneal lymphadenectomy for periampullary aednocrcinoma, part 2 : randomized controlled trial evaluating survival, morbidity, and mortality [J]. Ann Surg, 2002, 236 (6): 355-366,.
  • 10赵晓晏,尚瑞莲,夏时海,郭萍.原发性胰腺癌中p16基因突变及其蛋白表达的研究[J].重庆医学,2002,31(3):163-166. 被引量:8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部